Icon

EPRONTIA (nda214679)- (25MG/ML)

TOPIRAMATE AZURITY
25MG/ML
Yes No
2040-Aug-21 Expired
None None
None No
EPRONTIA is indicated for: 1.1 Monotherapy Epilepsy: EPRONTIA is indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. 1.2 Adjunctive Therapy Epilepsy: EPRONTIA is indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older. 1.3 Migraine: EPRONTIA is indicated for the preventive treatment of migraine in patients 12 years and older.
1 0 0
Total Other Developers 2
Drugs with Suitability No
25MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.